Client Story
How PHM helped Charles access multiple cutting edge therapies to stabilize his aggressive cancer.
Charles started having trouble swallowing, which worsened over time, leading Charles to look for answers. He was diagnosed with HER2 positive esophageal cancer and began a typical cancer treatment of chemotherapy and radiation. While he initially made progress, his cancer later returned, spreading to his lungs.
Charles decided he needed to do something different, and reached out to Private Health Management to explore additional treatment options for his cancer.
Private Health Management clinicians and researchers immediately began working in close collaboration with his treating oncologist to build Charles an individualized treatment plan.
Charles did not qualify for a clinical trial. However, with the help of Private Health Management, he did receive treatment under compassionate use. Within three months, CT scans showed shrinkage in his lung tumors, and he completed treatment a month later.
With his cancer lagerly managed, Charles became a candidate for a personalized cancer vaccine. Private Health Management’s care team coordinated the creation of his vaccine using tissues from prior biopsies, analyzing over 22,000 genes for specific mutations (neoantigens) that could trigger an immune response.
Shortly thereafter, Charles began receiving his personalized vaccine.
Following the initial vaccine schedule, Charles received his personalized vaccine every month with the plan to complete a full two years of vaccines – all while keeping the maintenance regimen Private Health Management developed specifically for Charles.
To this day, Charles‘ condition has remained stable – a testament to PHM’s thorough research of medical literature, expert clinical guidance, and tireless advocacy.
Discover our Why Wall
